Test Price
2,600 AEDโ Home Collection Available
Chromosomal Microarray 60K (Amniotic Fluid / CVS / Cord Blood) in UAE | 2,600 AED | DHA Licensed Laboratory
Executive Summary & Core Metrics
- Diagnostic Accuracy: 99.9% sensitivity via ISO 9001:2015 certified genomic processing (Certificate: INT/EGQ/2509DA/3139).
- Collection Protocol: Hospital Extraction Only โ Sample collection is conducted strictly within an accredited hospital facility; mobile home phlebotomy is disabled for safety.
- Clinical Guidance: Complimentary telephone consultation with a board-certified medical geneticist after result release.
- Insurance Verification: Direct WhatsApp check at +971 54 548 8731.
Test Overview & Methodology
The Chromosomal Microarray 60K (Amniotic Fluid / CVS / Cord Blood) test performs whole-genome scanning for submicroscopic deletions and duplications (copy number variations, CNVs) using a high-density Agilent 60K CGH+SNP array. It detects clinically significant microdeletions (e.g., DiGeorge, Prader-Willi), microduplications, regions of homozygosity indicative of uniparental disomy, and low-level mosaicism. This test is the standard of care for prenatal diagnosis of fetal structural anomalies, abnormal ultrasound findings, and family history of genetic conditions.
| Feature | CMA 60K (Agilent CGH+SNP) | Standard Karyotype |
|---|---|---|
| Resolution | ~60,000 probes โ detects gains/losses โฅ100 kb | 5โ10 Mb โ only large aneuploidies visible |
| Detection Spectrum | Submicroscopic CNVs, UPD, mosaicism, known syndromes | Whole-chromosome aneuploidies, major structural rearrangements |
| Turnaround Time | 7โ9 days | 10โ14 days |
| Price (AED) | 2,600 โ all inclusive | ~1,500 (basic) |
Physician Insight & Safety Protocols
โAs a DHA-licensed Consultant Medical Geneticist, I emphasise that the Chromosomal Microarray 60K test provides high-resolution genomic data that must be interpreted in conjunction with ultrasound findings, family history, and clinical context. The detection of a variant of uncertain significance (VUS) does not automatically indicate disease; correlation with parental studies and follow-up is essential. This test is a powerful tool but not a substitute for comprehensive genetic counseling or a physical examination.โ
โ Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Patient Safety: Exclusion Criteria & Red Flags
- Exclusion Criteria: Invasive sampling (amniocentesis, CVS, cordocentesis) is contraindicated when active intrauterine infection, uncontrolled bleeding diathesis, known allergy to local anaesthetics, or imminent miscarriage risk is present as determined by the attending obstetrician.
- Emergency Red Flags (post-procedure): Seek immediate medical attention if you experience severe abdominal pain, fever >38ยฐC, heavy vaginal bleeding, or sudden leakage of amniotic fluid.
A doctorโs prescription is mandatory. Home collection is not available for invasive prenatal specimens.
Patient FAQ & Clinical Guidance
1. What does the Chromosomal Microarray 60K test detect?
The test detects submicroscopic chromosomal gains and losses (copy number variations) across the entire genome with ~60,000 probes, revealing deletions and duplications as small as 100 kb. It identifies clinically significant microdeletions (e.g., 22q11.2 deletion, 15q11.2 deletion), microduplications, regions of homozygosity suggesting uniparental disomy, and low-level mosaicism. It does not detect balanced translocations or nucleotide-level mutations.
2. How is the sample collected, and what are the risks?
Sample collection requires a medically supervised invasive procedure performed by a trained specialist in a hospital setting: amniocentesis (risk of miscarriage ~0.1โ0.3%), chorionic villus sampling (similar risk), or cordocentesis (higher risk, used only when necessary). The procedure is only recommended when the diagnostic benefit outweighs the risk. Temperature-controlled transport follows ISO-certified cold-chain protocols to preserve specimen integrity.
3. When will I receive results, and how are they interpreted?
Results are typically available within 7 to 9 business days. The report classifies CNVs into benign, likely benign, variant of uncertain significance (VUS), likely pathogenic, or pathogenic. A VUS requires further family studies and clinical correlation. A normal result does not exclude all genetic conditions. A free telephone consultation with our genetics team is available to discuss implications.
UAE Regulatory & Data Privacy Adherence
Data Protection: This test complies with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genetic data is encrypted, access-controlled, and processed solely for diagnostic purposes. Patient consent and clinical documentation adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability.
Clinical & Logistical Metadata
| Test Name | Chromosomal Microarray 60K (Amniotic Fluid / CVS / Cord Blood) |
| Price (AED) | 2,600 (all inclusive) |
| Turnaround Time | 7โ9 business days |
| Sample Type / Matrix | Amniotic fluid, Chorionic villus sample (CVS), or Cord blood |
| Methodology Used | Agilent 60K CGH+SNP Array (Whole-genome microarray) |
| ICD-10-CM Code | O28.5 (Abnormal genetic and chromosomal findings in antenatal screening of mother), Z36 (Encounter for antenatal screening of mother) |
| LOINC Code | 92833-4 (Chromosomal microarray for prenatal specimen) |
| DHA Facility License & Laboratory Address | License No. 1143 โ Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE โ DNA Labs UAE |
ุฏุนู ุซูุงุฆู ุงููุบุฉ ู ุชุงุญ
ุงูุชุญูู ู ู ุงูุชุบุทูุฉ ุงูุชุฃู ูููุฉ
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
ุชููู ุนู ุงูุชุฎู ูู. ุฃุฑุณู ุตูุฑุฉ ู ู ุจุทุงูุฉ ุงูุชุฃู ูู ููุตูุฉ ุงูุทุจูุจ ุฅูู ูุฑูู ุงูุชุญูู ุงูู ุนุชู ุฏ ู ู ููุฆุฉ ุงูุตุญุฉ ุจุฏุจู ุนุจุฑ ุงููุงุชุณุงุจ. ุงุญุตู ุนูู ุชุญุฏูุซ ุงูุญุงูุฉ ูู ุฏูุงุฆู.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians